Cargando…
Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea
OBJECTIVE: The objective of this study was to evaluate the efficacy and safety of methylphenidate HCL OROS extended-release (OROS-MPH) among children with attention deficit hyperactivity disorder (ADHD) who had been previously treated with methylphenidate HCL immediate-release (MPH-IR). METHODS: The...
Autores principales: | Kim, Bung-Nyun, Kim, Ye-Ni, Cheong, Un-Sun, Kim, Jae-Won, Hwang, Jun-Won, Shin, Min-Sup, Cho, Soo-Churl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568652/ https://www.ncbi.nlm.nih.gov/pubmed/23430964 http://dx.doi.org/10.9758/cpn.2011.9.1.29 |
Ejemplares similares
-
Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
por: Ekinci, Ozalp, et al.
Publicado: (2017) -
Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
por: Buitelaar, Jan K., et al.
Publicado: (2012) -
Social adjustment and family function after drug switch from IR-methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou, Wen-Jiun, et al.
Publicado: (2018) -
The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
por: Rausch, Tessa L., et al.
Publicado: (2017) -
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder
por: Biederman, Joseph, et al.
Publicado: (2007)